Zekeriya Duzgun

发表

Role of mTOR in glioblastoma.

Ç. Biray Avcı, Zekeriya Duzgun, Z. Eroglu, 2016, Gene.

In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase

Zekeriya Duzgun, I. Celik, Meryem Erol, 2021, Molecular Diversity.

Identification of upregulated genes in glioblastoma and glioblastoma cancer stem cells using bioinformatics analysis.

Zekeriya Duzgun, Hasan Onur Caglar, 2022, Gene.

Molecular dynamic simulation and functional analysis of pathogenic PTEN mutations in glioblastoma

T. Akalın, Zekeriya Duzgun, H. Biceroglu, 2023, Journal of biomolecular structure & dynamics.

Interactions of the Receptor Binding Domain of SARS-CoV-2 Variants with hACE2: Insights from Molecular Docking Analysis and Molecular Dynamic Simulation

Zekeriya Duzgun, T. Emran, A. El-Shehawi, 2021, Biology.

Role of cardiac drugs and flavonoids on the IRE1–JNK pathway as revealed by re-ranked molecular docking scores, MM/PBSA and umbrella sampling

Zekeriya Duzgun, Z. Eroglu, 2020, Journal of biomolecular structure & dynamics.

In silico investigation of the interactions of certain drugs proposed for the treatment of Covid-19 with the paraoxonase-1

Zekeriya Duzgun, I. Yildiz, A. Orem, 2021, Journal of biomolecular structure & dynamics.

In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase

Zekeriya Duzgun, I. Celik, Meryem Erol, 2021, Molecular diversity.

FDI-6 inhibits VEGF-B expression in metastatic breast cancer: a combined in vitro and in silico study.

Zekeriya Duzgun, Funda Demirtaş Korkmaz, Egemen Akgün, 2024, Molecular diversity.